We are live on
!
Find out more
CAM
ClariVest Asset Management Portfolio holdings
AUM
$980M
1-Year Est. Return
60.89%
This Fund
S&P 500
This Quarter
Est. Return
+6.22%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$2.08B
AUM Growth
-$509K
(-0.02%)
Cap. Flow
-$56.1M
Cap. Flow
% of AUM
-2.7%
Top 10 Holdings %
Top 10 Hldgs %
31.07%
Holding
767
New
78
Increased
51
Reduced
369
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$11.6M |
| 2 |
United Airlines
UAL
|
+$8.44M |
| 3 |
Trade Desk
TTD
|
+$7.62M |
| 4 |
Deere & Co
DE
|
+$7.41M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$7.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$17.4M |
| 2 |
Meta Platforms (Facebook)
META
|
+$12.4M |
| 3 |
Generac Holdings
GNRC
|
+$7.5M |
| 4 |
Public Storage
PSA
|
+$6.95M |
| 5 |
Microsoft
MSFT
|
+$6.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.82% |
| 2 | Healthcare | 15.4% |
| 3 | Consumer Discretionary | 9.74% |
| 4 | Industrials | 8.81% |
| 5 | Financials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLP
401
DELISTED
Cantaloupe
CTLP
| $381K | 0.02% |
87,552
-1,100
| -1% | -$3.9K |
|
402
eHealth
EHTH
$43.9M
| $376K | 0.02% |
+77,500
| New | +$289K |
|
|
ITOS
403
DELISTED
iTeos Therapeutics
ITOS
| $366K | 0.02% |
18,700
-300
| -2% | -$5.86K |
|
404
Harvard Bioscience
HBIO
$29.2M
| $364K | 0.02% |
13,130
-190
| -1% | -$4.68K |
|
|
TGI
405
DELISTED
Triumph Group
TGI
| $363K | 0.02% |
34,500
-500
| -1% | -$5.17K |
|
|
PLYA
406
DELISTED
Playa Hotels & Resorts
PLYA
| $358K | 0.02% |
+54,879
| New | +$326K |
|
407
Distribution Solutions Group
DSGR
$1.61B
| $357K | 0.02% |
19,400
-400
| -2% | -$6.72K |
|
408
Regenxbio
RGNX
$708M
| $342K | 0.02% |
15,102
-24
| -0.2% | -$543 |
|
|
KZR
409
DELISTED
Kezar Life Sciences
KZR
| $336K | 0.02% |
4,780
-60
| -1% | -$4.45K |
|
410
Shoals Technologies Group
SHLS
$1.5B
| $327K | 0.02% |
13,290
+79
| +0.6% | +$1.91K |
|
411
MiMedx Group
MDXG
$633M
| $317K | 0.02% |
114,097
-184
| -0.2% | -$550 |
|
412
Vanda Pharmaceuticals
VNDA
$302M
| $314K | 0.02% |
42,500
-700
| -2% | -$6.82K |
|
|
SMAR
413
DELISTED
Smartsheet Inc.
SMAR
| $311K | 0.02% |
+7,905
| New | +$269K |
|
414
NeoGenomics
NEO
$2.13B
| $302K | 0.01% |
+32,662
| New | +$304K |
|
415
Veritone
VERI
$122M
| $301K | 0.01% |
56,749
-91
| -0.2% | -$583 |
|
416
iShares MSCI Saudi Arabia ETF
KSA
$621M
| $287K | 0.01% |
7,600
-28,700
| -79% | -$1.16M |
|
417
Intellia Therapeutics
NTLA
$1.67B
| $274K | 0.01% |
7,859
-13
| -0.2% | -$618 |
|
418
Butterfly Network
BFLY
$2.35B
| $253K | 0.01% |
102,600
-1,500
| -1% | -$5.38K |
|
419
Domo
DOMO
$184M
| $250K | 0.01% |
17,540
-33,390
| -66% | -$518K |
|
420
Amneal Pharmaceuticals
AMRX
$5.79B
| $195K | 0.01% |
97,810
-160
| -0.2% | -$359 |
|
421
iShares MSCI India Small-Cap ETF
SMIN
$776M
| $141K | 0.01% |
2,731
| – | – |
|
422
America Movil
AMX
$71.2B
| $140K | 0.01% |
7,700
-22,300
| -74% | -$412K |
|
423
Trip.com Group
TCOM
$29.1B
| $134K | 0.01% |
3,892
-600
| -13% | -$17.2K |
|
424
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$373M
| $122K | 0.01% |
2,519
| – | – |
|
425
Cameco
CCJ
$42.4B
| $116K | 0.01% |
5,100
| – | – |
|
Similar funds
GCAC
D
PP
FTIS
AIA
SEC
AFG
ECM
ClariVest Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, ClariVest Asset Management held 767 positions worth $2.08B, down 0.02% from $2.08B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
ClariVest Asset Management's Q4 2022 filing shows 78 new, 51 increased, 369 reduced and 77 closed positions. Its largest new stake was Block Inc: 187,789 shares worth $11.8M. The largest sale was Pfizer, an estimated $17.4M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- ClariVest Asset Management's largest Q4 2022 buy was Block Inc: 187,789 shares worth $11.8M.
- ClariVest Asset Management added most to United Airlines in Q4 2022, an estimated $8.44M increase.
- ClariVest Asset Management's biggest Q4 2022 reduction was Pfizer, cutting an estimated $17.4M.
- ClariVest Asset Management fully exited Generac Holdings in Q4 2022, selling an estimated $7.5M.
- ClariVest Asset Management's ten largest holdings make up 31% of its $2.08B portfolio in Q4 2022.
- ClariVest Asset Management opened 78 new positions and closed 77 in Q4 2022.
- ClariVest Asset Management's portfolio value fell 0.02% quarter-over-quarter to $2.08B.
Based on ClariVest Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.